Imperial College London
Alternate

DrAlexanderLyon

Faculty of Medicine, National Heart & Lung Institute

Honorary Clinical Senior Lecturer
 
 
 
//

Contact

 

+44 (0)20 7594 3409a.lyon Website

 
 
//

Location

 

ICTEM buildingHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Lyon:2020:10.1002/ejhf.1920,
author = {Lyon, AR and Dent, S and Stanway, S and Earl, H and Brezden-Masley, C and Cohen-Solal, A and Tocchetti, CG and Moslehi, JJ and Groarke, JD and Bergler-Klein, J and Khoo, V and Tan, LL and Anker, MS and von, Haehling S and Maack, C and Pudil, R and Barac, A and Thavendiranathan, P and Ky, B and Neilan, TG and Belenkov, Y and Rosen, SD and Iakobishvili, Z and Sverdlov, AL and Hajjar, LA and Macedo, AVS and Manisty, C and Ciardiello, F and Farmakis, D and de, Boer RA and Skouri, H and Suter, TM and Cardinale, D and Witteles, RM and Fradley, MG and Herrmann, J and Cornell, RF and Wechelaker, A and Mauro, MJ and Milojkovic, D and de, Lavallade H and Ruschitzka, F and Coats, AJS and Seferovic, PM and Chioncel, O and Thum, T and Bauersachs, J and Andres, MS and Wright, DJ and Lopez-Fernandez, T and Plummer, C and Lenihan, D},
doi = {10.1002/ejhf.1920},
journal = {EUROPEAN JOURNAL OF HEART FAILURE},
pages = {1945--1960},
title = {Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from theCardio-OncologyStudyGroup of theHeartFailureAssociation of theEuropeanSociety ofCardiology in collaboration with theInternationalCardio-OncologySociety},
url = {http://dx.doi.org/10.1002/ejhf.1920},
volume = {22},
year = {2020}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AU  - Lyon,AR
AU  - Dent,S
AU  - Stanway,S
AU  - Earl,H
AU  - Brezden-Masley,C
AU  - Cohen-Solal,A
AU  - Tocchetti,CG
AU  - Moslehi,JJ
AU  - Groarke,JD
AU  - Bergler-Klein,J
AU  - Khoo,V
AU  - Tan,LL
AU  - Anker,MS
AU  - von,Haehling S
AU  - Maack,C
AU  - Pudil,R
AU  - Barac,A
AU  - Thavendiranathan,P
AU  - Ky,B
AU  - Neilan,TG
AU  - Belenkov,Y
AU  - Rosen,SD
AU  - Iakobishvili,Z
AU  - Sverdlov,AL
AU  - Hajjar,LA
AU  - Macedo,AVS
AU  - Manisty,C
AU  - Ciardiello,F
AU  - Farmakis,D
AU  - de,Boer RA
AU  - Skouri,H
AU  - Suter,TM
AU  - Cardinale,D
AU  - Witteles,RM
AU  - Fradley,MG
AU  - Herrmann,J
AU  - Cornell,RF
AU  - Wechelaker,A
AU  - Mauro,MJ
AU  - Milojkovic,D
AU  - de,Lavallade H
AU  - Ruschitzka,F
AU  - Coats,AJS
AU  - Seferovic,PM
AU  - Chioncel,O
AU  - Thum,T
AU  - Bauersachs,J
AU  - Andres,MS
AU  - Wright,DJ
AU  - Lopez-Fernandez,T
AU  - Plummer,C
AU  - Lenihan,D
DO  - 10.1002/ejhf.1920
EP  - 1960
PY  - 2020///
SN  - 1388-9842
SP  - 1945
TI  - Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from theCardio-OncologyStudyGroup of theHeartFailureAssociation of theEuropeanSociety ofCardiology in collaboration with theInternationalCardio-OncologySociety
T2  - EUROPEAN JOURNAL OF HEART FAILURE
UR  - http://dx.doi.org/10.1002/ejhf.1920
UR  - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000555839800001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
VL  - 22
ER  -
Download